Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Increlex 10mg/ml solution for injection {equilateral_black_triangle}

Active Ingredient:
mecasermin
Company:  
Ipsen Ltd See contact details
ATC code: 
H01AC03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Increlex Hypoglycaemia Leaflet

Information for parents, caregivers, or for patients about hypoglycaemia and what to do if it occurs

{pdf_link}

Increlex Dosing Guide

{healthcare_pro_orange} For Healthcare Professionals

How to use Increlex in the treatment of severe primary IGF-1 deficiency

{pdf_link}

Increlex Physician Leaflet

{healthcare_pro_orange} For Healthcare Professionals

Physician information about Increlex® This educational material is essential to ensure the safe and effective use of the product and appropriate management of the important selected risks, and it is advised therefore that it be read carefully before prescribing/dispensing/administering the product.

{pdf_link}

Increlex Patient Leaflet

Patient educational information about severe primary IGF-1 deficiency and how Increlex® can help

{pdf_link}

Increlex Instructions for Use

This leaflet is a quick reference guide to preparing and injecting Increlex®

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Ipsen Ltd
Company image
Address
5th Floor, The Point, 37 North Wharf Road, London, W2 1AF, UK
Telephone
+44 (0)1753 627 777
Medical Information Direct Line
+44 (0)1753 627 777
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1753 627 627